Oncology Views & Analysis

Views & Analysis

Oncology

Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.

Oncology

Oncology

The NHS Cancer Plan has commissioned the Royal College of Radiologists with a formal review of opportunities to modernise Multi-Disciplinary Teams.

Oncology

At ASCO 26, Daiichi Sankyo leaders Ken Keller and John Tsai chatted with pharmaphorum about their big year of oncology launches, halfway in.

Oncology

Dr Peter Sasieni, co-investigator for the NHS Galleri trial, discusses advances in population-level blood screening for early cancer detection.

Oncology

The gap between what CAR-T can do and who can actually get it is the defining challenge of this field right now.